Clearstead Trust’s ICU Medical ICUI Stock Holding History

Clearstead Trust’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	-$840	–	1250
2025 Q3	$840	Hold	7	–	–	﹤0.01%	1265
2025 Q2	$926	Buy	+7	New	+$949	﹤0.01%	1186

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clearstead Trust's ICUI Position: Q4 2025 in Review

Clearstead Trust sold out of ICU Medical (ICUI) in Q4 2025, closing a stake of 7 shares — an estimated $840 sold.

Clearstead Trust first reported a position in ICUI in Q2 2025 and held it in 2 quarters. The position peaked at $926 in Q2 2025. 291 funds tracked by Wall St. Rank hold ICUI as of Q4 2025.

Clearstead Trust reported no remaining ICU Medical position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 7 ICU Medical shares in Q4 2025, an estimated $840.
Clearstead Trust first reported a position in ICU Medical in Q2 2025 and held it in 2 quarters.
Clearstead Trust's ICU Medical position peaked at $926 in Q2 2025.
291 funds tracked by Wall St. Rank held ICU Medical as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.